Lombard Odier Asset Management (Switzerland) SA - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (Switzerland) SA ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,789,000
-19.9%
258,214
-15.4%
0.24%
-19.7%
Q2 2022$3,480,000
-23.8%
305,253
-39.1%
0.30%
-17.6%
Q1 2022$4,566,000
-69.3%
501,219
-49.7%
0.36%
-62.3%
Q4 2021$14,862,000
-36.8%
996,116
+8.9%
0.95%
-35.0%
Q3 2021$23,500,000
+16.5%
914,416
+18.2%
1.46%
+42.6%
Q2 2021$20,174,000
+6.5%
773,562
+44.1%
1.02%
-18.6%
Q1 2021$18,947,000536,7381.26%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders